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ABSTRACT 
The purpose of this project was to determine if access to the National 
Comprehensive Cancer Network’s guidelines on the treatment of adult cancer related 
pain increased nurse practitioner knowledge and utilization in practice. The guidelines 
were provided to nurse practitioners who practiced within an oncology setting in North 
Dakota to assess whether their knowledge of pain management increased and if they 
found the guidelines to be a useful tool to have in practice. A pre-intervention 
questionnaire was sent to the participants to gain demographic information, including, 
age and gender, type of certification, primary area of practice, number of years practicing 
as an nurse practitioner, hours spent in clinical practice per week, and the average number 
of oncology patients seen per week. In addition, the pre-intervention questionnaire 
evaluated current treatment modalities the participants utilized in treating cancer related 
pain.  
After receiving the pre-intervention questionnaires, the National Comprehensive 
Cancer Network’s guidelines were distributed to the participants who agreed to utilize 
them for the duration of this project. The participants were given the full guidelines, a 
pocketbook of the guideline’s algorithms, and instructions for utilizing the phone 
application of the guidelines. A post-intervention questionnaire was sent out three months 
after the guidelines were distributed assessing their impact on nurse practitioner practice. 
Overall, the participants felt that the guidelines increased their knowledge on treatment 
modalities for cancer related pain and found them to be a useful resource in practice. 
From this project we can assume that the evidence based guidelines provided from the 
National Comprehensive Cancer Network are beneficial for novice and experienced nurse 
practitioners practicing in oncology. 
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CHAPTER 1. INTRODUCTION 
Background & Significance 
 Despite advances in pharmacotherapy, nursing care, and symptom control, cancer 
remains the second leading cause of death in the United States, just behind cardiovascular 
disease (Kochanek, Xu, Murphy, Minin, & Kung, 2011). In fact, cancer mortality rates 
have changed little over the last 50 years (Remington & Brown, 2011). Since the 1960’s, 
the mortality rates for breast, uterine, colon, stomach, and prostate cancers have declined; 
however, the death rate for lung cancer has increased, leading to the minimal decline in 
overall cancer mortality (Remington, & Brownson, 2011). In addition to the high 
mortality rates, annual incidence rates continue to increase. According to the American 
Cancer Society (2012), new cancer diagnoses in the United States will be more than 1.6 
million by the end of 2012. The estimates for new cancer diagnoses in 2012 are highest 
among prostate, breast, lung, and colon cancers (American Cancer Society [ACS], 2012).   
 Although mortality rates remain high, relative survival rates of cancer have 
increased from 50 percent in 1975 to 67 percent in 2007 (ACS, 2012). Relative survival 
rates are often examined in cancer research and indicate the number of patients surviving 
with a cancer diagnosis divided by the total population for a given period of time. The 
increase in relative survival is largely due to the advances taken in earlier diagnosis and 
treatment modalities (ACS, 2012). With an increase in survival time, symptom 
management, such as pain, will be a key component in the treatment of patients 
diagnosed with cancer.  
 Pain, dyspnea, and depression are the leading concerns for patients diagnosed 
with cancer (Lorenz et al., 2008). Cancer related pain is both worrisome to patients and 
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their providers. According to Jost and Roila (2010), pain is prevalent at some point 
during the disease process in more than 80 percent of cancer patients. Many patients 
diagnosed with cancer will benefit from the World Health Organization’s (WHO) 
analgesic ladder for pain management (Hagen, Biondo, & Stiles, 2008).  Although 
effectiveness has been shown, the WHO’s pain ladder is not adequate for the treatment of 
all cancer related pain, as shown by the continued high pain prevalence rates. 
 The National Comprehensive Cancer Network (NCCN) developed new guidelines 
in 2011 for the treatment of adult cancer related pain. The NCCN is a non-profit 
organization comprised of the world’s twenty-one leading cancer centers whose primary 
goal is to “improve the quality, effectiveness, and efficiency of oncology practice” 
(National Comprehensive Cancer Network [NCCN], 2011). Guidelines developed by the 
NCCN are based on the most current scientific evidence and reviewed by expert 
clinicians within the organization (NCCN, 2011). The pain management guidelines 
developed by the NCCN are specific to the type and intensity of the pain experienced by 
each individual patient. The use of the NCCN pain management guidelines is greatly 
needed in practice. Patients’ pain has not been adequately controlled in the past; however, 
the NCCN provides clinicians with alternative treatment options and dosing guidelines 
that will allow better control for individual patients (NCCN, 2011). Due to the recent 
publication of the guidelines, research is needed to estimate their utilization in practice.  
 Although most nurse practitioners (NPs) work autonomously, NPs working in an 
oncology practice do not have their own patients. Cancer patients are managed by an 
oncologist, or a medical doctor who has specialized in cancer care, because of the 
extensive nature of the disease. NPs working in oncology will become key providers in 
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the care of cancer patients in the near future due to the shortage of medical oncologists 
and the increasing rate of new cancer diagnoses (ACS, 2012). New graduate NPs will be 
asked to fill the oncology role in many facilities. Rosenzweig et al. (2010) examined the 
knowledge needed by first year NPs practicing in oncology and found over 70 percent of 
those surveyed believed they were not proficient in managing oncologic emergencies, 
including pain management. The results of the study by Rosenzweig et al. (2010) show 
an increased need for oncology-related education and resources for the novice NP.  
Problem & Purpose of the Project 
Effectively treating cancer related pain has been shown to be difficult. The NCCN 
has provided a set of specific cancer pain treatment guidelines that would help novice and 
expert NPs in the treatment of cancer related pain. Due to the relatively recent 
development of the NCCN guidelines, there is a lack of research on the number of NPs 
who utilize them in practice and on the perceived barriers related to underutilization. The 
purpose of this practice improvement project was to 1) identify the demographics of 
North Dakota NPs who practiced in oncology, 2) identify current treatment strategies 
utilized by North Dakota NPs practicing in oncology in the treatment of cancer related 
pain, 3) provide NPs with specific evidence-based guidelines from the NCCN, and 4) 
investigate if utilization of the NCCN guidelines improves their practice.  
Project Goals 
1. NPs practicing in oncology within North Dakota will become familiar with the 
NCCN guidelines and algorithms on the treatment of adult cancer pain by having 
the guidelines readily available in practice. 
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2. NPs practicing in oncology within North Dakota will utilize the NCCN guidelines 
on the treatment of adult cancer pain in practice. 
Project Objectives 
1. Identify the number of NPs who practice in oncology in North Dakota. 
2. Identify demographics of the participants, including age and gender, type of 
certification, primary area of practice, number of years practicing as an NP, hours 
spent in clinical practice per week, and the average number of oncology patients 
seen per week.  
3. Identify current treatment modalities of pain utilized by North Dakota NPs 
practicing in oncology. 
4. Identify if NPs practicing in oncology in North Dakota are utilizing the NCCN 
guidelines in practice pre and post intervention.  
5. Identify barriers to the utilization of the NCCN guidelines in practice.  
6. Identify if having the NCCNs evidence-based guidelines and algorithms on adult 
cancer pain treatment increases NP utilization and understanding, thus improving 
practice. 
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CHAPTER 2. LITERATURE REVIEW 
 Cancer is a general term used to describe many diseases. Normally, cells within 
the tissues of the body grow and divide in a controlled manner. When these normal cells 
become damaged or old, the body replaces them with new cells (National Comprehensive 
Cancer Network [NCCN], 2011). Cells that divide in an uncontrolled manner are given 
the term cancer. The development of these abnormal cells stems from damage or an 
unexpected change in the genetic material located within each of the body’s cells 
(National Cancer Institute [NCI], 2011). The damaged cells produce mutations that alter 
the sequence of cell growth, division, and death, leading to an excess of mutated cells. 
The extra mutated cells will sometimes form together to create a tumor, or mass of tissue; 
however, not all cancers form tumors (NCI, 2011). Mutated cells that do not form tumors 
cause an overcrowding of cells leading to impaired bodily functions (NCCN, 2011). For 
consistency purposes throughout the project cancer was stated as any malignant disorder 
in which cells abnormally grow. This chapter explores a number of areas. The beginning 
of the chapter explains the definition of cancer and cancer related pain, the theoretical 
framework used to guide the project, and past and present cancer pain management. The 
latter half of the chapter provides clarification of a NP, NPs role in cancer pain 
management, NPs current knowledge and utilization of the NCCN guidelines, and gaps in 
the literature.                                                                          
Classification of Cancers 
Once a tumor has been formed, nutrition in the form of blood supply develops and 
provides continued growth. The body becomes deprived of nutrients in order to feed the 
tumor, leading to the characteristic symptom of unexplained weight loss in an otherwise 
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healthy individual. Spreading of cancer cells to other parts of the body can occur via the 
lymphatic system and blood supply. The spreading of malignant cells, or metastasis, 
leads to reinvasion of adjacent cells, allowing the cancer to grow at a new location (NCI, 
2011). The cancer cells may be found within the body at various locations but are named 
according to the primary tumor’s origin. For example, cancers that originate in the colon 
are termed colon cancer, while cancers that originate in the breast are termed breast 
cancer. 
 Grading and staging of the cancer occurs after the primary location of origin is 
determined. A numerical grade is assigned to most cancers based upon microscopic 
examination. Cancer cells with fewer abnormalities are given a low grade number, either 
grade I or II, while those with many abnormalities receive a higher grade number, either 
III or IV (NCI, 2011). Staging refers to the severity of the cancer based upon the size of 
the tumor, whether lymph nodes have been invaded, and whether the original cancer has 
spread to other parts of the body (NCCN, 2011).           
Cancer Related Pain 
Pain is one of the most common symptoms patients diagnosed with cancer 
experience. Cancer pain can be caused by a number of factors. Malignant cells that 
invade nearby tissue and organs often cause pain because of the increased pressure 
applied to these locations. Destruction and inflammation of tissue, and cancer treatment 
can also cause pain (Copstead & Banasik, 2010). Pain associated with cancer treatment is 
typically related to invasive procedures such as biopsies and tumor removal; however, 
intravenous administration of chemotherapy has also been shown to cause pain.  
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Many different types of cancer related pain exist. The type of pain is related to the 
pathophysiology mechanisms: nociceptive and neuropathic (NCCN, 2011). Nociceptors 
are present in the circulatory system, skin, muscle, and viscera (Copstead & Banasik, 
2010). Injury or damage to somatic and visceral structures cause the release of 
nociceptors. Somatic nociceptive pain is often described as sharp, throbbing, and 
localized (NCCN, 2011). Somatic pain typically occurs as a result of bone metastases or 
from invasive surgical procedures (NCCN, 2011). Pain described as aching, cramping, or 
diffuse is often visceral nociceptive pain, and is caused by compression and infiltration of 
the cancer cells (NCCN, 2011). Neuropathic pain occurs as a result of injury to the 
central nervous system (CNS) or peripheral nervous system. Sharp, burning, or shooting 
pain is often neuropathic (NCCN, 2011).    
Pain intensity is also measured by assigning a numerical value from the patient. 
Pain intensity provides the starting point for treatment. A pain scale of 0 to 10 is 
primarily used; however, pictorial scales can be used for patients who have limited 
English proficiency or for developmentally delayed patients. The pain should also be 
described by character (i.e., stabbing, shooting, ect.) in order to provide the appropriate 
analgesic (NCCN, 2011).  
 Although many treatment modalities exist, pain continues to be a concern for 
cancer patients and their providers. Van den Beuken-van Everdingen et al.  (2007), 
reviewed the prevalence of pain over the past 40 years. Prevalence of pain in earlier 
studies ranged from 52 percent to 77 percent (van den Beuken-van Everdingen et al., 
2007). Newer studies show similar results in the prevalence of pain. Van den Beuken-van 
Everdingen et al. (2007) found pain prevalence between 24 percent and 60 percent in 
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patients receiving treatment for cancer and in 62 percent to 86 percent of patients who 
had wide-spread, or metastatic, disease. Oldenmenger et al. (2011) also found that more 
than two-thirds of cancer patients experience pain.  
Theoretical Framework 
 The Symptom Management Model (SMM) is the theoretical framework used to 
guide this project. Nurse researchers at the University of California, San Francisco 
developed the model which has been widely used by clinicians in assessing and providing 
treatment of multiple symptoms (Yarbro, Frogge, & Goodman, 2004). The model has 
been specifically utilized in numerous studies on the management of pain (Yarbro et al., 
2004). The model assumes the following: 
1. The only way to truly know a symptom is through individuals’ self-report; 
2. The symptom does not have to be currently experienced by an individual. 
They can be considered at high-risk for developing the symptom through 
environmental related variables. During this time the individual may be 
treated for the predicted symptom; 
3. Individuals who cannot verbally communicate symptoms still experience 
symptoms;  
4. Management of symptoms may be targeted at individuals, families, groups, or 
the environment; 
5. Symptom management is a dynamic process; that is, individual outcomes can 
modify the symptom experience. 
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The SMM is also based on the assumption that effective management of a 
symptom can only occur by considering the symptom experience, symptom management 
strategies, and the outcomes (Yarbro et al., 2004).  
 Symptom experience encompasses the individual’s beliefs or perceptions about 
the symptom. The symptom experience also looks at how the individual responds to the 
symptom. Such responses can include physiological, behavioral, and cultural 
components, all which have an effect on the individual experience.  
 Symptom management strategies include the individual’s self-care strategies, 
along with health care providers’ recommendations for symptom management. Strategies 
include who delivers what, where, when, how, to whom, how much, and why (Yarbro et 
al., 2004). The goal of symptom management is to prevent negative outcomes during 
patient care. In order to prevent poor outcomes, the SMM focuses on the assessment of 
symptoms and proper treatment for those symptoms. The current project examines pain 
assessment completed by NPs on a numerical scale of 0 to 10, and then examines 
evidence-based treatment modalities depending on the pain rating. The SMM recognizes 
that one treatment modality may not be beneficial when repeated, leading health care 
providers to modify treatment strategies over a time period (Yarbro et al., 2004). The 
NCCNs guidelines for treating adult cancer related pain also recognize pain and treatment 
modalities as individual and recommend changes for providers to follow in practice.      
 Outcomes of symptom management are direct evidence of the individual’s 
symptom experience and management strategies. The outcomes look at the status of the 
symptom, whether it has improved or declined. The individual’s functional status, 
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emotional status, morbidity, quality of life, and costs are all a part of the symptom 
management outcome (Yarbro et al., 2004).  
                 
  
 
 
The SMM provides clinicians with a guide when assessing and managing 
individual’s symptoms. The model helps describe the relationship between the symptom 
experience, management strategies, and the varied outcomes of one’s life. Health care 
providers are able to choose appropriate interventions based upon individual experiences 
and perceptions, and then monitor the results of those interventions. The model also 
allows for clinicians to continuously provide symptom assessment and management for 
an infinite amount of time. NPs entering into oncology practice will benefit from the use 
Figure 1. The symptom management model. From: Dodd M, Janson S, Facione N 
Faucett J, Froelicher ES, Humphreys J, Lee K, Miaskowski C, Puntillo K, Rankin S, 
Taylor D. (2001). Advancing the science of symptom management. Journal of 
Advanced Nursing, 33(5), 668-676. Reprinted with permission from Verity Butler, 
Permissions Assistant, John Wiley & Sons, October 27, 2011. 
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of the SMM because of the clarity and ease of use. The SMM has been used in numerous 
pain management studies and proven an effective model to guide research. 
Guidelines for Treatment 
World Health Organization’s Pain Ladder 
The most common and widely used guideline for the treatment of cancer pain 
originates from the World Health Organization (WHO). This guideline is most commonly 
known as the pain ladder. Established in 1986, the “ladder” consists of a three step 
approach in the treatment of cancer pain (World Health Organization [WHO], 2011). The 
first “step” recommended by the WHO is prompt delivery of an oral non-opioid, followed 
by “step” two which consists of a mild opioid if the pain is not relieved from use of a 
non-opioid (WHO, 2011). The third and final “step” on the ladder consists of using a 
strong opioid until the patient is free from all cancer pain. The WHO gives a list of 
medications to be used during each step of the ladder. Examples of non-opioids include 
aspirin and paracetmol; mild opioids include codeine; and strong opioids include 
morphine (WHO, 2011).  
The pain ladder recommends using an adjuvant in addition to each step previously 
listed. Antidepressants and anxiolytics are considered the primary adjuvant in order to 
help relieve any fear or anxiety the patient may have (WHO, 2011). All of the medication 
given should be given around the clock, instead of on an as needed basis in order to 
ensure freedom from pain. The pain ladder suggests administering the medications every 
three to six hours for maximum effectiveness (WHO, 2011).  
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Oldenmenger et al. (2011) found that even with around-the-clock analgesic 
administration following the WHO pain ladder, 10 to 30 percent of patients did not 
receive adequate pain control. This was due to a number of factors, including 
uncontrolled side effects preventing further administration of the analgesic and improper 
dosing of opioids (Oldenmenger et al., 2011). In order to overcome some of these 
barriers, Oldenmenger et al. (2011) recommended a slight alteration to the WHO pain 
ladder. They found that rotating opioids was found to be effective in 85 to 90 percent of 
patients with advanced cancer requiring strong opioids (Oldenmenger et al., 2011). 
Similar findings were given in the research completed by Moryl, Coyle, and Foley 
(2008). Moryl et al. (2008) found that individual differences in the response and tolerance 
to opioids required many cancer patients to trial two or three opioid drugs in order to find 
Figure 2. The World Health Organization’s Pain Relief Ladder (WHO, 
2011), reprinted October 5, 2011. 
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any relief from pain. By rotating opioids, side effects were minimal and adequate pain 
control was achieved.  
 The “pain ladder” appears simple, and easy for all practitioners to use; however, 
there are critics of the WHOs pain ladder. Research by Hagen, Biondo, and Stiles (2008) 
comments on the lack of treatment options for breakthrough cancer pain in the WHO’s 
pain ladder. They found that managing cancer pain was more complex than a simple 
three-step approach and required more thorough recommendations (Hagen et al., 2008). 
Hagen et al. (2008) also recommend skipping steps in the pain ladder in order to treat 
sudden, breakthrough pain. Instead of starting out on step one, strong opioids such as 
morphine, hydromorphone, fentanyl, and methadone should be used initially when a 
patient presents with intense pain (Hagen et al., 2008). Green et al. (2009) found similar 
results in their study on breakthrough and chronic cancer pain. Seventy-nine percent of 
patients studied were found to experience breakthrough pain varying in intensity and 
location (Green et al., 2009). In order to provide effective pain management in patients 
experiencing breakthrough pain, bypassing the first two levels of the pain ladder will 
eliminate unnecessary medications and time, rendering the ladder ineffective. 
 The National Comprehensive Cancer Network (2011) has also commented on the 
simplicity of the three-tiered pain ladder. Lack of dosing and opioid selection is one of 
the primary concerns the NCCN has with the WHO pain ladder (NCCN, 2011). 
Mercadante et al. (2008) also found that other opioids were more effective than the 
limited recommendation for the use of morphine in severe cancer pain. In their study, 
Mercadante et al. (2008) compared the effects of oral sustained-release morphine, 
transdermal fentanyl, and oral methadone on cancer pain. The results showed that oral 
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methadone and transdermal fentanyl were more effective in treating severe cancer pain; 
however, methadone was the superior drug (Mercadante et al., 2008). Although dosing of 
methadone needed to be changed more frequently, the oral preparation was less 
expensive, had fewer side effects than morphine, and provided the patients with relief 
from pain.  
Specific recommendations regarding the type of non-opioid and opioid used in the 
WHO pain ladder was given by Jost and Roila (2010). Non-opioids consisting of 
acetaminophen, ibuprofen, acetylsalycic acid, keoprofen, diclofenac, naproxen, and 
mefenamic acid were recommended for the first step in the ladder (Jost & Roila, 2010). 
Step two recommendations for the use of mild opioids included dihydrocodeine and 
tramadol in addition to one of the recommended step one analgesics (Jost & Roila, 2010). 
The last step of the pain ladder would include strong opioids such as morphine, 
oxycodone, hydromorphone, fentanyl, buprenorphine, methadone, and nicomorphine 
(Jost & Roila, 2010). The recommendations for neuropathic pain were amitryptiline, 
clomipramine, nortriptyline, fluoxetine, haloperidol, chlorpromazine, carbamazepine, 
gabapentin, and pregabalin (Jost & Roila, 2010). Along with providing individual step 
recommendations, Jost and Roila (2010) list appropriate dosing information, adverse 
effects, time of onset, and maximum daily doses. These specific guidelines are not 
included within the WHO pain ladder but will be of benefit to the novice practitioner in 
treating cancer related pain.   
 Research has also shown that the WHO pain ladder may not be effective for all 
types of cancer pain. Bell, Eccleston, and Kalso (2003) looked specifically at neuropathic 
pain and the use of the surgical anesthetic ketamine hydrochloride. They found that low-
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dose ketamine reduced the need for morphine and “significantly reduced pain intensity in 
cancer pain with a neuropathic component” (Bell et al., 2003). Xiong et al. (2009) also 
found that site-specific pain was not easily controlled using the pain ladder suggested by 
the WHO. In their study, Xiong et al. (2009) examined effective pain management of 
pancreatic cancer. Between 60 and 90 percent of the subjects in the study experienced 
pain using standard opioids treatment. The use of high intensity focused ultrasound 
ablation relieved pain in 80.6 percent of the patients (Xiong et al., 2009). Identification of 
pain location, type, and intensity is relevant in utilizing the pain ladder’s 
recommendations for treatment. 
NCCN Clinical Guidelines in the Treatment of Adult Cancer Pain 
 The WHO pain ladder has been widely used and is an effective teaching tool; 
however, the NCCN developed clinical guidelines and algorithms in 2011 for the 
treatment of adult cancer pain that is highly specific and detailed. The guidelines are 
based on scientific evidence and reviewed by expert clinicians within the NCCN (NCCN, 
2012). These new recommendations are the result of previous cancer pain management 
research which has shown that new guidelines were needed due to the consistent 
prevalence of pain among cancer patients. Lorenz et al. (2008) conducted a systematic 
review utilizing over 1,200 articles showing that effective treatment of cancer pain was 
established using opioids, NSAIDs, and radionuclides. The results of the systemic review 
conducted by Lorenz et al. (2008) are consistent with the 2011 recommendations given 
by the NCCN for cancer pain treatment. Thus, the guidelines are shown to follow years 
of evidence-based research of what was effective and not effective in the management of 
adult cancer related pain. Algorithms and pain intensity are key components within the 
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guidelines. Intensity is given a numerical value and treatment modalities are then based 
off that rating (NCCN, 2011). Other essential elements of the NCCN guidelines include: 
• a comprehensive pain assessment performed at each visit;  
• availability of psychosocial support; 
• disease and pain specific education material provided to the patient; 
• dosing guidelines for opioids, non-opioids, and adjuvant analgesics; 
• suggestions for titration and rotation of opioids; 
• suggestions for the escalation of opioids dosage; 
• management of opioids adverse effects;  
• when to proceed to other interventions for cancer pain treatment. 
A number of factors are taken into account when addressing pain management for cancer 
patients and are all addressed by the NCCN guidelines. For the purpose and scope of this 
paper, only pharmacological pain management treatment will be addressed. Non-
pharmacological pain management, such as massage, psychosocial support, and adjuvant 
treatment options will not be discussed. 
 The comprehensive pain assessment addresses intensity, character, and also looks 
at the duration, onset, location, associated factors, current treatment, effects on lifestyle, 
and the patient’s goals and expectations of pain management. The pain assessment also 
includes a detailed physical examination, appropriate imaging studies, and laboratory 
reports in order to provide specific therapy. The goal is for the practitioner to be able to 
differentiate somatic, visceral, or neuropathic cancer pain in order to provide the 
appropriate treatment (NCCN, 2011). 
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 Three levels of pain intensity are used in the management of cancer pain and are 
based upon the numerical rating between 0 and 10 (NCCN, 2011). Mild pain is 
considered to be rated between 1 and 3; moderate pain is rated between 4 and 6; and 
severe pain is between 7 and 10 (NCCN, 2011). In addition to pain rating, algorithms 
were created based on oncologic emergencies, opioid tolerant patients, and opioid naïve 
patients (NCCN, 2011).  
 Oncologic emergencies are pain related to brain, epidural, or leptomeningeal 
metastases; pain related to infection or obstruction; and bone pain secondary to a fracture 
(NCCN, 2011). Opioid tolerant patients are differentiated from opioid naïve patients in 
that they chronically take opioids for the treatment of cancer related pain, while opioid 
naïve patients do not. NCCN (2011) has defined opioid tolerant utilizing the definition 
provided by the U.S. Food and Drug Administration (FDA) as the following: 
Patients taking at least 60 mg oral morphine per day, 25 mcg transdermal fentanyl 
per hour, 30 mg oral oxycodone per day, 8 mg oral hydromorphone per day, or 25 
mg oral oxymorphone per day. Patients who do not fall within the above category 
are considered to be opioid naïve. 
Distinguishing opioid tolerant versus naïve patients is essential to providing the 
appropriate treatment. By determining which category the patient falls within, NPs will 
be able to provide specific dosing, titration, and maintenance medications.  
 In determining the appropriate opioid and dose, the NCCN recommends utilizing 
an individual approach based on the patient’s pain intensity, location, and exposure to 
opioids in the past (2011). Treatment of opioid naïve patients’ mild pain, rated as 1 to 3, 
should be treated with a non-opioid analgesic, such as acetaminophen or a non-steroidal 
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anti-inflammatory drug, or NSAID (NCCN, 2011). This recommendation is consistent 
with the WHO pain ladder. Moderate pain, rated 4 to 6, in opioid naïve patients are 
treated similar to those with severe pain, rated 7 to 10 (NCCN, 2011). The difference in 
treatment of moderate and severe pain in these patients is the starting dose and titration of 
short-acting opioids (NCCN, 2011). Opioid tolerant patients are typically given an opioid 
dosed at 10 to 20 percent the total daily dose for breakthrough pain. The opioid of choice 
for breakthrough pain is one with a rapid onset and short half-life (NCCN, 2011).  
Mild pain, rated 1 to 3 on the pain scale, should be treated with NSAIDs, 
specifically ibuprofen 400 mg four times per day, or ketorolac 15 to 30 mg intravenously 
every six hours (NCCN, 2011). NSAIDs should be avoided in patients with 
thrombocytopenia; renal, cardiac, or gastrointestinal toxicities; or hepatic failure (NCCN, 
2011). Acetaminophen 650 mg every four hours is recommended when the patient is 
thrombocytopenic or at risk of developing another bleeding disorder. Low-dose opioids 
should be administered after two NSAIDs are tried without relief of pain (NCCN, 2011).  
 Opioid naïve patients presenting with moderate pain are recommended to start 
with short-acting oral morphine at a dose of 5 to 15 mg (NCCN, 2011). If pain persists 
after 60 minutes, an increase in dosage by 50 to 100 percent is recommended until the 
pain has subsided. After 2 or 3 unsuccessful attempts at pain relief, intravenous morphine 
at a dose of 2 to 5 mg is recommended (NCCN, 2011). Hydromorphone, fentanyl, and 
oxycodone can also be used because of their short half-lives and ease of titration (NCCN, 
2011). 
 For opioid tolerant patients presenting with moderate pain, a calculation of the 
previous 24 hours total dosage should be calculated and a breakthrough dose of 10 to 20 
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percent should be given orally (NCCN, 2011). If pain persists after 60 minutes, an 
increase in dosage by 50 to 100 percent is recommended until the pain subsides. 
Subsequent pain after 2 or 3 failed attempts requires intravenous administration (NCCN, 
2011). Both opioid tolerant and opioid naïve patients should be switched to another 
opioid if the current prescribed opioid is not effective or is causing severe adverse effects. 
These recommendations are summarized in table 1. 
Table 1. Recommendation for treatment based on pain intensity.  
Pain Type & 
Rating 
Intervention  Recommended Drug & Dosage 
Mild 1-3 Non-opioid analgesic NSAIDs 
    -Ibuprofen 400 mg 4 times/day 
    -Ketorolac 15-30 mg IV every 6 
hours 
Acetaminophen 650 mg every 4 hours 
Low-dose opioids as needed 
Moderate 4-6 Short-acting opioid Morphine 5-15mg oral or 2-5 mg IV; 
increase by 50-100% or switch to 
another opioid if pain not relieved after 
2-3 attempts 
Severe 7-10  Opioids/long & short 
acting  
Morphine 5-15mg oral or 2-5 mg IV; 
increase by 50-100% or switch to 
another opioid if pain not relieved after 
2-3 attempts 
Opioid tolerant 
patients  
Opioids/long & short 
acting with 
breakthrough opioids 
as needed 
For breakthrough pain, calculate the 
past 24 hours dose and administer 10-
20 % of the total dose 
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Different types of cancer pain, such as nerve and bone pain, should be treated 
with opioids, as well as with additional therapies. Specific treatment recommendations 
provided by NCCN (2011) are the following: 
• Inflammatory pain should be treated with NSAIDs or glucocorticoids; 
• Nerve compression or inflammation treated with glucocorticoids; 
• Bone pain without oncologic emergency should be treated with NSAIDs, 
radiation therapy, nerve blocks, bisphosphonates, chemotherapy, 
glucocorticoids, or radioisotopes; 
• Bowel obstructions treated with bowel rest, nasogastric suction, 
glucocorticoids, and octreotide; 
• Neuropathic pain treated with an antidepressant, anticonvulsants, or 
topical agents, and 
• Painful lesions treated with radiation, hormones, or chemotherapy. 
The NCCN has provided practitioners with a detailed and specific set of guidelines to be 
followed in the treatment of cancer pain.  
Definition of a Nurse Practitioner 
An advanced practice nurse (APN) is an umbrella term used to describe a 
registered nurse (RN) with additional graduate education in areas of advanced nursing 
theory, physical and psychosocial assessment, and treatment of illness (American College 
of Nurse Practitioners [ACNP], 2008). A NP is a “licensed independent practitioner who 
has been educated at the graduate level, with a minimum of a master’s degree” (Nevidjon 
et al., 2010).  
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NPs take detailed health histories and provide complete physical examinations; 
diagnose and treat many common acute and chronic problems; interpret laboratory results 
and imaging studies; prescribe and manage medications and other therapies; provide 
health teaching and supportive counseling with an emphasis on prevention of illness and 
health maintenance; and refer patients to other health professionals as needed (American 
Academy of Nurse Practitioners [AANP], 2011). 
NPs can provide leadership, deliver quality care, as well as ensure comprehensive 
care through development, implementation, and evaluation of systems to manage costs 
and attain quality outcomes (AANP, 2011). NPs work in collaboration with physicians, 
which means that the physician agrees to be readily available to the NP for consultation 
regarding patient cases (AANP, 2011). NPs are also given prescriptive privileges which 
vary from state to state. North Dakota NPs currently do not require a collaborative 
agreement with a physician when prescribing medication (AANP, 2011).  
The Need for NPs in Cancer Care 
 The American Society of Clinical Oncology (ASCO) conducted workforce 
studies in an attempt to understand the current supply and needs of oncologists through 
the year 2020 (Hortobagyi, 2007). From the study, the ASCO learned that by 2020 the 
demand for cancer services will greatly outweigh the number of available oncologists. 
Oncologists care primarily for the aging population which is expected to double between 
the year 2000 and 2030 (Erikson, Salsberg, Forte, Bruinooge, & Goldstein, 2007). With 
the increasing age of the United States population, there will be an increase in cancer 
diagnoses and cancer survivors, all needing the care of an oncology specialist. Along 
with the increasing age of the general population, oncologists will also continue to age 
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and go into retirement. The ASCO study projected that there will only be an increase of 
1,322 oncologists nationwide from the years 2010 to 2020 (Erikson et al., 2007). This 
calculates to only a 12 percent increase in a highly needed medical specialty, while 
oncology services are projected to increase by 48 percent, leading to a shortage of over 
3,800 oncologists in 2020 (Hortobagyi, 2007).  Recommendations have been put into 
place by ASCO in order to meet the demands of the growing oncology population. The 
first recommendation is to increase the number of fellowship spots in order to attract 
more physicians. A 50 percent increase in fellowship spots still leaves a dramatic 
shortage in cancer care (Erikson et al., 2007). Another downfall is the route oncologists 
need to follow. An internal medicine residency is needed prior to selecting a specialty, 
with the majority choosing more lucrative specialties (Erikson et al., 2007). The second 
recommendation is to increase the number of NPs working in oncology. Studies have 
previously shown that physicians who currently work with an NP have higher weekly 
visit rates than those that do not (Erikson et al., 2007). NPs trained in advanced roles such 
as ordering chemotherapy and performing invasive procedures would allow for an 
increase in productivity (Erikson et al., 2007). The third recommendation is to allow 
primary care providers (PCP) to monitor patients in remission which could alleviate 
shortages in oncology. Unfortunately, many physicians are leaving primary care either 
through retirement or to specialties other than oncology (Erikson et al., 2007). Thus, NPs 
will be needed to fill in the role of oncology specialists in increasing numbers by the year 
2020.  
Nationally, there are over 167,000 licensed NPs, but only 652 have the specialty 
certification of an Advanced Oncology Certified NP, or AOCNP (Nevidjon et al., 2010). 
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In order to obtain the title of an AOCNP, the NP must have completed an accredited NP 
educational program, hold an active, valid license, and have completed a minimum of 
500 hours as an NP practicing in oncology (Nevidjon et al., 2010). Working in an 
oncology practice does not require a NP to hold the certification of AOCNP, evidenced 
by the rare numbers nationally. In fact, the majority of NPs practicing in oncology hold 
broader certifications, such as family medicine (Nevidjon et al., 2010).  
Gap in the Literature 
 NPs will play an instrumental role in the treatment of cancer related pain through 
accurate and thorough pain assessments and treatment. The WHO’s pain ladder has been 
the mainstay of cancer related pain treatment; however, the NCCN guidelines provide 
NPs with more comprehensive and specific treatment modalities. Due to the relatively 
recent development of the NCCN guidelines, North Dakota NPs utilization and 
understanding of the guidelines are unknown. The NCCN also provides algorithms that 
could prove to be of benefit to not only new graduate NPs entering the oncology 
workforce, but also to experienced NPs currently practicing in oncology. Currently there 
is no literature available demonstrating the use of the NCCN algorithms or their efficacy. 
NPs need to be able to understand the most evidence-based guidelines in the management 
of cancer related pain in order to provide safe and effective care for their patients. 
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CHAPTER 3. PROJECT DESIGN 
 The NCCN has provided a new, comprehensive set of guidelines to aid NPs in the 
treatment of adult cancer pain; however, the knowledge and use of these guidelines was 
unknown. The goals of the current practice improvement project (PIP) were: 
1. NPs practicing in oncology within North Dakota will become familiar with the 
NCCN guidelines and algorithms on the treatment of adult cancer pain by having 
the guidelines readily available in practice. 
2. NPs practicing in oncology within North Dakota will utilize the NCCN guidelines 
on the treatment of adult cancer pain in practice.  
The project design was to elaborate on the objectives by: 
Step 1: Identifying the number of NPs who practice in oncology in North Dakota. 
Step 2: Identifying demographics of the participants, including age and gender, 
type of certification, primary area of practice, number of years practicing as a NP, 
hours spent in clinical practice per week, and the average number of oncology 
patients seen per week.  
Step 3: Identifying current treatment modalities of pain utilized by North Dakota 
NPs practicing in oncology. 
Step 4: Identifying if having access to the NCCN guidelines would be beneficial 
to North Dakota NPs practicing in oncology. 
Step 5: Distributing the NCCN guidelines to North Dakota NPs practicing in 
oncology. 
Step 6: Identify if NPs practicing in oncology in North Dakota are utilizing the 
NCCN guidelines in practice pre and post intervention.  
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Step 7: Identify barriers to the utilization of the NCCN guidelines in practice.  
Step 8: Identify if having the NCCNs evidence-based guidelines and algorithms 
on adult cancer pain treatment increases NP utilization and understanding, thus 
improving practice. 
A timeline for the project can be found in Appendix A. North Dakota State 
University Institutional Review Board approval, as an expedited project, was sought and 
granted prior to initiation of the project.   
A list of the NPs practicing in an oncology setting in North Dakota was gathered 
during the literature review. There were nine NPs found to be practicing in oncology 
clinics within North Dakota. The nine NPs practicing in oncology in North Dakota were 
sent a professional letter with a link to a survey, a paper form of the survey, and an 
agreement for use of the guidelines form (Appendix E).The letter was prepared by the 
author and printed on NDSU letterhead. The letters were distributed by the United States 
Postal Service and through personal communication to the nine NPs practicing in 
oncology between May and June 2012. The letter contained basic information, such as 
the purpose of the project, the survey link, expiration date, and contact information of the 
primary and co-investigator. Recipients interested in completing the survey were asked to 
follow the link provided and complete the survey or to complete a printed version of the 
survey along with the agreement for use form (Appendix E). The first page of the survey 
consisted of an explanation of the nature and scope of the practice improvement project, 
description of the questionnaire, approximate time commitment, and informed consent 
instructions. NPs that consented to participate were told to follow the link provided on 
the letter or start the paper survey. They then completed the survey. If the NP chose to 
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complete the paper version of the survey, only twelve questions were asked, along with 
the separate agreement of use form (Appendix E). If the NP chose to complete the online 
version of the survey, thirteen questions were asked, with the additional question being 
the agreement for use of the guidelines. The electronic link to the survey was made 
possible through Survey Monkey, a secure online website allowing individuals to create 
surveys, collect responses, and analyze data. Participating NPs were asked to provide 
personal information including name, address, and phone number for distribution of the 
evidence-based guidelines from the NCCN, a pre-test, post-test, and ten dollar Starbucks 
gift certificate pending completion of both the initial and final survey. Demographic 
questions were asked followed by one open-ended question, three multiple choice 
questions, one additional open- ended question, and lastly a yes or no question on the 
online version of the survey only. The letters were distributed once in May 2012, with 
one reminder mailed out in June 2012. Access to the survey was closed in August 2012. 
To assume confidentiality, all identifying information entered by the NPs was 
permanently deleted and not published.  
Sample Description 
 The project population used during this practice improvement project included 
NPs who practice in an oncology clinic within the state of North Dakota. Of the nine NPs 
in North Dakota, five practiced in Fargo, three practiced in Grand Forks, and the 
remaining NP practiced in Bismarck. The author had a working relationship with the NPs 
practicing in oncology in Fargo, North Dakota, and was therefore projecting a minimum 
response rate of 55 percent, although a 100 percent response was anticipated.    
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Questionnaires 
Pre-Intervention   
Questionnaires were developed specifically for this PIP. The pre-intervention 
questionnaire (Appendix B) was developed to gather demographic information, 
determine the current treatment modalities utilized in the treatment of adult cancer related 
pain, obtain current knowledge NPs in North Dakota have on the NCCN pain 
management guidelines, and identify any perceived barriers to the usage of the 
guidelines. To provide a common reference from which to answer the questions related to 
treatment, cancer was stated to be any malignant disorder in which cells abnormally 
grow. Adults were also given a common reference as any person age 18 and older. 
 In the pre-intervention survey, the initial section of the questionnaire was intended 
to collect demographic information about the participants. The purpose of question one 
was to get information on the age range of the participants. Options for age range 
included 25 to 35, 36 to 45, 46 to 55, 56 to 65, and > 65 years old. Question two asked 
the participants to identify their gender; being either male or female, and a third option 
was to not answer the question. Question three was meant to obtain information on area 
of NP certification. The choices were family NP (FNP), oncology NP (ONP), women’s 
health NP (WHNP), pediatric NP (PNP), geriatric NP (GNP), or other. For persons who 
chose other, a free text response was recommended. NPs practice in numerous settings, 
therefore question four was tailored to obtain information on the practice settings of the 
respondents. Options included oncology ambulatory care, primary ambulatory care, 
inpatient hospital care, and other. For participants who chose other, instructions to 
specify their practice settings by free text in the space provided were given. Given that 
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years of practice can have an effect on knowledge base of a practitioner, question five 
was included to help gather information on years of practice of the respondents. The 
options were 0 – 5 years, 6 – 10 years, 11 – 15 years, 16 -20 years, and > 20 years. 
Question six was meant to obtain information on number of hours in clinical practice per 
week and the options were 10 hours or less, 11 – 20 hours, 21 – 30 hours, 31 – 40 hours, 
and 41 hours or more per week. The last question on demographics was coined to find 
out the average number of patients diagnosed with cancer seen per week by the NPs who 
responded to the questionnaire. The options were 1 to 10, 11 to 20, 21 to 30, 31 to 40, 41-
50, and > 50 patients. 
 The next part of the questionnaire was keyed to identifying current treatment 
modalities utilized by NPs practicing in oncology in North Dakota. Question eight asked 
the participants to identify any current pain management guidelines used to guide 
practice. Response options for question eight were left open for the participant to fill in. 
Question nine consisted of asking NPs practicing in oncology in North Dakota about their 
current familiarity of the 2011 NCCN adult cancer pain treatment guidelines. The options 
for this question were a) Very familiar, I utilize them frequently in practice, b) Somewhat 
familiar, I have utilized them a couple times in practice, c) Somewhat unfamiliar, I have 
heard of them but have never utilized them in practice, and d) Very unfamiliar, I have 
never heard of them and do not utilize them in practice. The following question then 
assessed any barriers to the use of the NCCN guidelines for treating cancer pain. The 
options included a) lack of education on the guidelines, b) use different guidelines for 
treating cancer related pain, c) have not heard of the 2011 NCCN adult cancer pain 
treatment guidelines, d) have not had time to look over the specific recommendations of 
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the NCCN 2011 guidelines, and e) other. If a participant chose “other” for the previous 
question, a free text option was given as to the specific barriers they encountered.  
 Due to the length and complexity of the NCCN guidelines in treating adult cancer 
related pain, a simplified algorithm or algorithms may be of benefit to novice and 
experienced practitioners. In order to evaluate if the project intervention would be 
beneficial to the NPs in practice, the eleventh question asked if they felt that having the 
evidence-based NCCN guidelines and algorithms would increase the utilization and 
understanding of pain treatment. The options for question eleven were a) yes, b) 
somewhat, c) maybe, d) probably not, or e) definitely not. Question twelve was an open 
ended question focused on finding out the challenges NPs practicing in oncology 
encountered when treating cancer related pain. Response options for question twelve 
were left open for the participant to fill in. The last question on the online version of the 
survey looked at whether the participants would agree to utilization of the guidelines after 
distributed. The options for the last question were “yes” or “no”. 
 After creation of the survey, the author obtained feedback from a five member 
committee consisting of three Doctor of Philosophy professors at North Dakota State 
University (NDSU), one DNP who is also a nursing professor at Concordia College in 
Moorhead, Minnesota, and one NP who also teaches nursing at NDSU.  
Recommendations were made and changes were added accordingly. There was no pilot 
project prior to implementation.  
Post-Intervention 
The post-intervention questionnaire (Appendix C) was developed to assess 
whether the implemented intervention helped to improve practice in treating cancer 
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related pain among the NPs practicing in North Dakota. The post-intervention survey 
consisted of eight questions. Questions one through four attempted to ascertain the 
participants’ utilization of the guidelines. The first four questions utilized a Likert scale 
consisting of strongly disagree, disagree, undecided, agree, and strongly agree. The first 
question asked if the guidelines were used after distribution. The second question aimed 
to determine if the guidelines continued to be utilized by the participants. The third 
question aimed to identify if having the guidelines and algorithms in practice helped 
increase the participants’ knowledge of cancer related pain treatment modalities. The 
fourth question asked if the participants believed the guidelines and algorithms were a 
useful tool to have in practice.  
The next two questions aimed to identify any enabling factors or barriers to 
utilizing the guidelines in practice. Question five aimed to find out what helped increase 
utilization of the guidelines in practice. The options were a) having the full set of 
guidelines available, b) having a pocketbook of the algorithms and treatment options 
available, c) having the option to utilize a phone application of the guidelines, d) having a 
desire to learn more about treatment options, and e) other. If the participant chose “other” 
as a response in question five, a free text option was given. Question six then assessed 
any barriers to the usage of the guidelines. The options included a) lack of education on 
the guidelines, b) use different guidelines for treating cancer related pain, c) have not 
heard of the 2011 NCCN adult cancer pain treatment guidelines, d) have not had time to 
look over the specific recommendations of the NCCN 2011 guidelines, and e) other. If a 
participant chose “other” for the previous question, a free text option was given as to the 
specific barriers they encountered.  
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The seventh question asked the participants to provide specific information on 
how they believed the NCCN guidelines have helped to improve their practice in the 
management of adult cancer related pain. The last question on the post-intervention 
survey asked for any additional comments in regards to the NCCN guidelines or 
suggest1ions which would help to improve pain management outcomes in cancer care. 
The last two questions were given free text space for the participants to provide their 
responses. The post-intervention survey was sent out three months after implementation 
of the intervention to allow for ample utilization time of the guidelines in practice. 
Responses were gathered through Survey Monkey and paper surveys, depending on 
which method the participant preferred.  
Intervention Implementation 
 After the results were gathered from the pre-intervention survey, the evidence-
based guidelines and algorithms originally created by the NCCN were distributed to the 
original participants who agreed to use them in practice for a minimum duration of one 
month with a maximum of three months. The guidelines and algorithms were taken from 
the NCCN 2011 guidelines on the treatment of adult cancer pain with permission for 
redistribution (Appendix D). A full set of the evidence-based guidelines were 
professionally printed and placed in a spiral bound book by the author of this project.1 
The algorithms for acute and chronic opioid users were professionally laminated, made 
1 Reproduced with permission from the NCCN Clinical Practice Guidelines in Oncology 
(NCCN Guidelines©) for Adult Cancer Pain (V.2.2011) ©2012 National Comprehensive 
Cancer Network, Inc. Available at: NCCN.org. Accessed February21, 2012. To view the 
most recent and complete version of the NCCN Guidelines©, go on-line to NCCN.org. 
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into a spiral bound flip chart, and distributed by the author. For participants who utilize 
electronic resources, instructions on how to download the phone application from the 
NCCN for use of the guidelines was also provided (Appendix F). The guidelines, 
algorithms, and phone application instructions were then sent to the participants who had 
agreed to utilize the guidelines in practice as indicated from the pre-intervention 
questionnaire. The post-intervention survey was sent to the original participants three 
months after the guidelines were provided to them. After results from the post-
intervention survey were obtained, Starbucks gift certificates in the amount of ten dollars, 
along with thank you letters were sent out to the participants in August and September 
2012.   
Evaluation 
 Upon completion of the individual surveys, the results were interpreted by the 
statistics department at NDSU and were based on the total number of participants that 
completed surveys. All of the results were based on a percentage of the total number of 
participants. On the pre-intervention survey, questions one through seven obtained 
demographic information of the participants, which identifies objective two of the 
project. Questions eight and nine helped to identify the current treatment strategies 
utilized by NPs practicing in oncology, which helped identify objective three of this 
project. Questions ten and eleven were keyed to determine the participants’ familiarity, 
utilization, and barriers of the NCCN 2011 guidelines, which helped in identifying 
objectives four and five. Question twelve helped to identify objective six by analyzing if 
the NPs would find the NCCN’s algorithms to be beneficial in practice and whether 
having them readily available would increase their utilization. Question thirteen was the 
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online agreement stating that the participant would utilize the guidelines for a specified 
period of time which helped to identify the validity of the results. The post-intervention 
survey then helped to determine whether the guidelines improved NPs practice. 
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CHAPTER 4. RESULTS 
 The purpose of this project was to identify current treatment strategies utilized by 
North Dakota NPs practicing in oncology in the treatment of cancer related pain, provide 
those NPs with specific evidence-based guidelines from the NCCN, and investigate if 
utilization of the NCCN guidelines improved their practice. Participants included the NPs 
who worked in an oncology setting in North Dakota at the time the project was initiated.  
Project Goals & Objectives 
The goals of the current PIP were the following: 
1. NPs practicing in oncology within North Dakota will become familiar with the 
NCCN guidelines and algorithms on the treatment of adult cancer pain by having 
the guidelines readily available in practice. 
2. NPs practicing in oncology within North Dakota will utilize the NCCN guidelines 
on the treatment of adult cancer pain in practice.  
The following objectives were used in this project: 
1. Identify the number of NPs who practice in oncology in North Dakota. 
2. Identify demographics of the participants, including, age and gender, type of 
certification, primary area of practice, number of years practicing as an NP, hours 
spent in clinical practice per week, and the average number of oncology patients 
seen per week.  
3. Identify current treatment modalities of pain utilized by North Dakota NPs 
practicing in oncology. 
4. Identify if NPs practicing in oncology in North Dakota are utilizing the NCCN 
guidelines in practice pre and post intervention.  
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5. Identify barriers to the utilization of the NCCN guidelines in practice.  
6. Identify if having the NCCNs evidence-based guidelines and algorithms on adult 
cancer pain treatment increases NP utilization and understanding, thus improving 
practice. 
Description of the respondents, project results, and analyses of the responses to 
both the pre-intervention and post-intervention questionnaires are presented in this 
chapter. Participant demographics, including age and gender, practice location, and 
practice characteristics were identified. Responses were gathered on the participants’ 
familiarity with NCCN cancer pain management guidelines and barriers encountered 
during utilization. Follow-up responses were evaluated as to the degree of benefit the 
participants felt the NCCN guidelines provided. The following chapter takes an in-depth 
look at the results of the project.  
Description of Respondents 
 NPs practicing in an oncology setting in North Dakota and licensed by the North 
Dakota Board of Nursing were invited to participate in this project. The initial 
questionnaire was sent to nine NPs identified as practicing within an oncology setting in 
North Dakota; however, due to attrition of two NPs, the final sample consisted of seven 
NPs. The attrition was due to job changes to different specialty fields, which disqualified 
those participants from participating in the project.  
 The pre-intervention survey was sent out on May 17, 2012, with a reminder sent 
out two weeks later to participants who had not yet responded. The majority of 
participants (67%) completed the online version of the survey, while the others 
completed and mailed in the paper questionnaire. Of the seven NPs surveyed, six replied. 
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Figure 3. Age ranges, in years, obtained from North Dakota NPs who practice in an 
oncology setting. 
An initial response rate of 55% was anticipated due to the professional connection of this 
writer with several NPs in an oncology setting; however, the actual response rate of 86% 
(n=6) was significantly higher than expected. 
Demographics 
 The pre-intervention questionnaire assessed the demographics of the surveyed 
participants. All of the respondents were female, and the majority (67%) were between 
the ages of 25 and 35. Of the remaining respondents, 16% were between the ages 36 and 
45, and 16% were 46 to 55 years old. There were no respondents over the age of 56 
(Figure 3). A mean age could not be calculated due to the interval age ranges the 
respondents were given to choose from versus identifying an actual age.   
 
   
 
 NP certification was evaluated, and included the following six possible responses: 
1. FNP, family NP 
2. ONP, oncology NP 
3. WHNP, women’s health NP 
67% 
16% 
17% 
Age in years of NPs (n=6) 
25-35 years
36-45 years
46-55 years
>56 years
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4. PNP, pediatric NP 
5. GNP, geriatric NP 
6. Other (respondents were asked to specify via a free text option) 
All of the respondents (100%) were certified family NPs, with one (16%) having 
an additional certification as an Advanced Oncology Certified Nurse Practitioner 
(AOCNP). In order to be certified as an AOCNP, the NP needed to meet eligibility 
requirements of the Oncology Nursing Certification Corporation (ONCC). In addition to 
being a master’s or doctorate prepared NP, the ONCC requires applicants have “a 
minimum of 500 hours of supervised clinical practice as an adult oncology NP” 
(Oncology Nursing Certification Corporation [ONCC], 2011).   
 The majority (83%) of respondents worked in an oncology ambulatory care 
setting. If a respondent chose “other” for their primary area of practice, a free text 
response was encouraged. One respondent (17%) chose “other”, and the free text given 
for primary practice setting was “both inpatient and outpatient” oncology care. The 
options that were not chosen included primary ambulatory care and inpatient hospital 
care. 
 NP experience, hours worked per week, and number of patients seen per week 
were also evaluated as demographics of the participants. When identifying the length of 
time practicing as a NP, the options included: 0 to 5 years, 6 to 10 years, 11 to 15 years, 
16 to 20 years, and more than 20 years. The majority (67%) of respondents indicated that 
they have been a practicing NP for less than or equal to 5 years. The remaining 33% 
chose 11 to 15 years as the duration of time practicing as a NP (Figure 4).     
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The last questions in the demographic section looked at the amount of time spent 
in clinical practice each week and the average number of oncology patients seen per 
week. The answers were varied when assessing the amount of time spent in practice per 
week. The respondents were given five options as answers and the hours ranged from 
zero to more than 41 hours per week (Figure 5). Sixteen percent spent between 11 and 20 
hours in practice, 16% between 21 and 30 hours, 33% between 31 and 40 hours, and 33% 
spent more than 41 hours per week in clinical practice.  
The average number of oncology patients seen per week also varied among 
respondents and ranged from 11 to 50 (Figure 6). Thirty-four percent indicated that they 
saw an average of 11 to 20 patients per week, 34% saw between 21 and 30 patients per 
week, 16% saw between 31 and 40 patients per week, and 16% saw between 41 and 50 
patients per week.  
 
67% 
33% 
Time in years as a practicing NP 
0-5 years
6-10 years
11-15 years
16-20 years
>20 years
Figure 4. Duration of time in practice, in year ranges, obtained from North Dakota 
NPs who practice in an oncology setting. 
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Figure 6. Average number of oncology patients seen per week obtained from North 
Dakota NPs who practice in an oncology setting. 
Figure 5. Number of hours spent per week in clinical practice obtained from North 
Dakota NPs who practice in an oncology setting. 
 
 
 
 
 
  
In summary, all of the respondents were female and were certified as FNPs. The 
majority (67%) were between the ages of 25 and 35. Eighty-three percent worked in an 
oncology ambulatory care setting and 67% indicated that they have been a practicing NP 
16% 
16% 
34% 
34% 
Number of hours spent per week in clinical practice 
10 or less
11-20 hours
21-30 hours
31-40 hours
>40 hours
34% 
34% 
16% 
16% 
Average number of oncology patients seen per week 
1-10 patients
11-20 patients
21-30 patients
31-40 patients
41-50 patients
>50 patients
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for less than or equal to 5 years. Thirty-three percent of respondents worked between 31 
and 40 hours, and 33% spent more than 41 hours per week in clinical practice. Thirty-
four percent indicated that they saw, on average, between 11 and 20 patients per week, 
and another 34% of respondents saw between 21 and 30 patients per week. 
Treatment Modalities 
The second half of the pre-intervention questionnaire was keyed to identifying 
current treatment modalities utilized by NPs practicing in oncology in North Dakota and 
to identify current knowledge of the NCCN guidelines on the treatment of adult cancer 
related pain. Sixty-seven percent of the respondents indicated they did not follow any 
guidelines when treating cancer related pain, 16% of respondents indicated they followed 
the NCCN guidelines, and 16% stated they did not follow any specific guideline 
consistently, but instead made treatment choices based on the following: 
• Previous history and use of pain medications,  
• What has worked in past,  
• What they are able to understand, 
• What other medications may complicate or add further risk to a selection of pain 
medications, and 
• What is the patient willing to take?  
• Are they able to follow instructions and take the medication correctly? 
After identifying treatment guidelines used in practice, knowledge of the NCCN 
guidelines on the treatment of adult cancer pain and barriers to utilizing the guidelines 
were evaluated. The majority of respondents (50%) indicated that they were somewhat 
unfamiliar with the guidelines in that they had heard of the guidelines but had never 
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Figure 7. Familiarity with the NCCN 2011 guidelines on the treatment of adult 
cancer pain obtained from North Dakota NPs who practice in an oncology setting. 
utilized them in practice. Thirty-three percent of the respondents indicated that they were 
somewhat familiar with the guidelines and had utilized them a couple of times in 
practice, and 17% of the respondents indicated that they were very familiar with the 
guidelines and utilized them frequently in practice (Figure 7). 
 
 
  
Thirty-three percent of the respondents indicated that having a lack of time to 
look over the specific recommendations of the NCCN guidelines was the biggest barrier 
encountered, while another 33% of respondents indicated that the biggest barrier to 
utilization of the guidelines was a lack of education. Of the remaining respondents, 16% 
indicated they utilized different guidelines in treating cancer related pain and 16% did not 
answer the question. 
 In order to evaluate if the intervention would benefit the NPs who practice in 
oncology, the questionnaire assessed the respondents’ opinion on whether having the 
guidelines and algorithms provided by the NCCN would increase utilization and 
17% 
50% 
33% 
Familiarity with the NCCN 2011 guidelines on the treatment of 
adult cancer related pain 
Very familiar, I utilize them
frequently in practice
Somewhat familiar, I have utilized
them a couple of times in practice
Somewhat unfamiliar, I have
heard of them but have never
utilized them in practice
Very unfamiliar, I have never
heard of them and do not utilize
them in practice
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understanding. The majority of the respondents (83%) indicated that utilization and 
knowledge would increase if the NCCN guidelines on the treatment of adult cancer 
related pain were provided. The remaining 17% of respondents indicated that ‘maybe’ 
utilization and knowledge of the guidelines would increase if provided. 
 Caner pain has shown to be challenging for providers and patients. The last 
question on the pre-intervention questionnaire aimed to gather specific challenges 
encountered by the respondents. The results varied, and included the following: 
• Lack of education, 
• Patient compliance issues, 
• Staff nurses not knowledgeable about pain treatment options, 
• Multiple other medications and possible interactions, 
• Intractable neoplastic pain with increasing tolerance to medications, 
• Patient preferences regarding treatment, 
• History of drug abuse, 
• Lack of willingness from the patient to try other methods of pain control, and 
• Providing adequate pain control without experiencing medication side effects.  
Fifty percent of the respondents had indicated that medication tolerance was one of the 
biggest challenges encountered when managing cancer related pain. The other responses 
varied among the respondents. 
 To ensure the validity of the post-intervention questionnaire, the respondents were 
asked to utilize the guidelines in practice for up to three months. Eighty-three percent of 
the respondents agreed to utilize the guidelines, while the remaining 17% of respondents 
said they would not agree to utilize the NCCN guidelines in practice. As a result, this 
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17% of respondents was excluded from the intervention and post-intervention 
questionnaire. The final portion of the project then consisted of the five participants who 
completed the initial survey and agreed to utilize the guidelines in practice. 
Utilization of the NCCN Guidelines 
 The post-intervention questionnaire was mailed to the five participants who 
agreed to utilize the guidelines in practice three months after the intervention was 
distributed. Four of the five participants, or 80%, responded to the post-intervention 
questionnaire. Respondents’ beliefs on utilization of the NCCN guidelines are 
summarized in Table 2. For each question respondents were asked to rate their 
agreeability with the statement provided. The responses included 1) strongly disagree, 2) 
disagree, 3) undecided, 4) agree, and 5) strongly agree. Twenty-five percent of the 
respondents strongly disagreed to all four of the statements made. Fifty percent of the 
respondents utilized the guidelines in practice after distribution; however, only 25% 
continue to utilize the guidelines. The majority (75%) of respondents agreed or strongly 
agreed that the intervention increased their knowledge of cancer related pain treatment 
modalities. Seventy-five percent of respondents also agreed or strongly agreed that the 
intervention provided was a useful tool to have in practice. 
 The majority (80%) of respondents did not answer the last two questions on the 
post-intervention survey, which we could assume was due to a lack of time, as indicated 
in previous questions. Twenty percent responded that the guidelines helped improve 
practice by having opioid conversion charts when switching medications and 20% stated 
that the booklet was very helpful to refer to in practice. 
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Table 2. Utilization beliefs as reported by North Dakota NPs practicing in oncology  
 SD% D% U% A% SA% 
I utilized the guidelines in practice after 
they were distributed. 
25 0 25 50 0 
I continue to utilize the guidelines in 
practice. 
25 0 50 25 0 
The guidelines and algorithms provided to 
me increased my knowledge of cancer 
related pain treatment modalities. 
25 0 0 50 25 
The guidelines and algorithms are a useful 
tool to have in practice.  
25 0 0 50 25 
SD, strongly disagree; D, disagree; U, undecided; A, agree, SA, strongly agree. 
 
One comment made in regards to the NCCN guidelines was: “Nice to have easy access to 
tables to answer questions. NCCN is often used in many other areas of cancer from 
treatment to education. Often times I forget that this is available for pain management as 
well.” 
In summary, 50% of the respondents utilized the guidelines in practice after 
distribution, 75% of respondents felt that the intervention increased their knowledge of 
cancer related pain treatment, and 75% of respondents felt the intervention was useful to 
have in practice.  
 This chapter presented the project findings and explained the findings in relation 
to the posed project objectives and goals. This writer utilized the statistics department at 
NDSU for analysis of the data. The frequency statistics were provided and interpreted. 
An attrition of two occurred prior to beginning the project, and an attrition of one 
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occurred after the pre-intervention survey was distributed. An interpretation of the data, a 
summary of the project results, implications for practice, limitations of the project, and 
recommendations for future projects are included in Chapter 5. 
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CHAPTER 5. DISCUSSION & CONCLUSIONS 
 In 2012, over 1.6 million people were diagnosed with cancer (ACS, 2012). North 
Dakota had a total of more than 33,000 cancer patients in 2012, with 3,510 being new 
diagnoses (ACS, 2012). Although the number of new cancer cases continues to rise, 
advances in medical technology and disease management have increased patients’ 
relative survival time an average of 20 years (ACS, 2012). With this increase come 
additional complications, including increased pain, nausea, and other medical 
comorbidities.  
The purpose of this project was to 1) identify the demographics of North Dakota 
NPs who practice in oncology, 2) identify current treatment strategies utilized by North 
Dakota NPs practicing in oncology in the treatment of cancer related pain, 3) provide 
NPs with specific evidence-based guidelines from the NCCN, and 4) investigate if 
utilization of the NCCN guidelines improved their practice. Participants included NPs 
who practiced in an oncology setting within North Dakota at the time the project was 
initiated. The overall goals of the project were to have the participants become familiar 
with, and utilize the NCCN guidelines on the treatment of adult cancer related pain in 
practice.  
This chapter offers a summation of the project findings, including an examination 
of the respondents’ demographic characteristics, barriers to treating cancer related pain, 
and benefit of the intervention. The implications for NP practice, limitations of the 
project and suggestions for further project development will be offered. 
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Summary of Results 
 The data collected shows that the majority of NPs practicing in an oncology 
setting in North Dakota are between the ages of 25 and 35 and have been practicing for 
no more than five years. The data also showed that the majority of these NPs do not 
follow any specific guideline when treating cancer related pain. While this could be for a 
number of reasons, looking at the demographic data we could assume that a lack of 
education, familiarity with treatment options, and specialty training or certification in an 
oncology setting are the primary causes. Only participant one stated they followed the 
NCCN guidelines in practice prior to the intervention. This data is somewhat surprising 
given that the NCCNs guidelines were developed from the world’s leading cancer centers 
and based on the most current evidence-based treatment options (NCCN, 2011). 
Participant one also had a specialty certification, AOCNP, and had been practicing as an 
NP for more than five years. The majority of the other participants knew of the guidelines 
but had only utilized them infrequently. The data showed that not having enough time 
and a lack of education to be the most common reasons that the guidelines are not used in 
practice. We can conclude from these results that having a specialty certification and 
more years of practice as an NP creates more knowledge about the use of evidenced 
based pain management guidelines in cancer care.  
 The overall goal of the project was to increase NPs knowledge and utilization of 
the NCCN guidelines, which would in turn decrease the pain intensity experienced by 
oncology patients. According to the data collected, the guidelines provided to the NPs 
helped to increase their knowledge of cancer related pain management, and showed that 
the NPs found the guidelines to be a useful tool in practice. We can then assume that use 
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of the NCCN guidelines in practice decreases oncology patients’ pain intensity. The 
majority of the participants felt that having the guidelines in practice would help to 
increase their utilization. Given these results, we are left questioning why one participant 
would not agree to utilize the NCCNs guidelines in practice. The NP who did not agree to 
utilize the guidelines did not provide rationale behind this decision and was not contacted 
for further details; however, according to Shaneyfelt and Centor (2009), reasons 
clinicians choose to not utilize guidelines vary. During their research, Shaneyfelt and 
Centor found that providers felt guidelines were too comprehensive and not patient 
specific (2009). Research has also shown that provider’s attitudes and beliefs about 
patient care limit their use of practice guidelines (Shaneyfelt & Centor, 2009).  Many 
guidelines have also been found to expire or have newer versions, leading to confusion 
amongst providers on which version to follow (Shaneyfelt & Centor, 2009).  
Previous studies have shown that more than 70 percent of new NPs working in an 
oncology setting believed they were not proficient in managing cancer related pain 
(Rosenzweig et al., 2010). The project findings add to the body of knowledge that more 
education is needed amongst NPs entering into an oncology setting. The lack of 
education in oncology could be due to a number of reasons, including a lack of training in 
graduate school, a lack of on-the-job training, or the need for specialty certification in 
oncology. Prior to discussing the recommendations for future projects and education, the 
limitations of the project will be discussed.  
Limitations 
 There were several limitations of this project. This project was limited to only the 
NPs working in North Dakota and thus cannot be generalized to the entire United States. 
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The project only looked at NPs in the oncology setting, which also prohibits the results 
from being generalized to the entire NP population as a whole. Nine NPs were initially 
found to be working in an oncology setting in North Dakota; however, two of those NPs 
left oncology for other specialty areas. Reasons for leaving the oncology field were not 
looked at in this project but may be beneficial for other projects in the future. Due to the 
small sample of the project, the results found could not be considered statistically 
significant and statistical calculations could not be completed.  
 The timing and duration of the project’s intervention was another key limitation. 
The intervention took place over three months and was in place over the summer months 
of June through August. Participants may not have felt they had adequate time to utilize 
the guidelines in practice, or possibly worked less in the summer months than they do at 
other times during the year. Although duration of the intervention was short, adequate 
time was not indicated as a barrier to utilization on the post-intervention survey. In fact, 
50 percent of the participants indicated that they used the guidelines in practice after they 
were distributed.  
 A lack of prior research on the use of the NCCN guidelines can also be viewed as 
a limitation of this project. The relatively recent development of the guidelines makes this 
limitation somewhat unavoidable. The guidelines were developed in 2011 and there was 
no literature found on their use in practice within North Dakota oncology care NPs. This 
project does provide background about the benefit of using the guidelines in NP practice 
for future projects and research.      
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Recommendations & Implications for Practice 
 While these project findings have contributed to the body of knowledge regarding 
NP management of cancer related pain and the use of the NCCN guidelines, replication 
of this project would help to confirm the results. Modifying the project to include all NPs 
practicing in oncology within the United States would give more generalized results. 
Increasing the duration of time of future projects would allow us to see if the guidelines 
were beneficial long term and whether NPs would continue to utilize the guidelines when 
caring for patients with cancer. Following patient charts after the intervention was in 
place would be a good indicator if the guidelines proved to be beneficial in treating 
cancer related pain. This would need to be done as a longitudinal study to focus on the 
different types of cancer pain and stage of disease being treated. In addition, further 
research with other NP specialties and the use of evidence based guidelines within those 
specialties would be beneficial to see if similar results ensued. This would allow us to see 
if having guidelines helped improve NP practice as a whole or just within certain 
specialties. 
 In addition to future project recommendations, the results indicate that a lack of 
education is a key barrier when treating cancer related pain. In addition to obtaining a 
generalized degree, specialized training courses, certifications, and continuing education 
related to the oncology field should be considered as a part of an oncology NPs 
requirements for practice. Including courses related to oncology care within graduate 
schools’ curriculums would also provide new graduate NPs with more knowledge on pain 
types and management techniques.  
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 Although this project was limited to NPs practicing in an oncology setting, all 
NPs play a role in pain management. According to the American Academy of Pain 
Medicine (AAPM), over 100 million Americans suffer from chronic, non-cancer pain 
(2011). Pain has been shown to affect more Americans than coronary heart disease and 
diabetes combined (American Academy of Pain Medicine [AAPM], 2011). Many of the 
common diagnoses seen routinely in family practice will be associated with pain. Some 
of the diagnoses include osteoarthritis, diabetes, migraines, sports-related injuries, and 
infections. Research has shown that chronic non-cancer pain is seen in a primary care 
setting 33% of the time (Nicholson & Passik, 2007). Nicholson and Passik (2007) also 
found that many primary care providers are hesitant in prescribing opioids for treating 
chronic pain due to concerns about possible disciplinary action. The guidelines provided 
by the NCCN on the treatment of adult cancer related pain provide an in-depth look at 
opioid prescribing and how to convert between opioids. Primary care providers, including 
NPs, could become skilled at managing chronic pain with opioids if they were provided 
with the NCCNs conversion charts and guidelines which explain how and when to utilize 
each opioid therapy in practice.  
Conclusion 
Cancer is one of the most rapidly growing chronic illnesses in the United States 
(ACS, 2012). According to the American Cancer Society (2012), the lifetime risk for 
developing any form of cancer ranges from 38 to 48 percent, with males at a higher risk 
than females. Advances in pharmacotherapy and technology have allowed cancer patients 
to live longer; however, symptoms related to cancer remain prevalent and difficult to 
manage. According to the NCCN (2011) more than 25% of patients with a new diagnosis 
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of cancer exhibited pain, more than 50% of patients undergoing cancer treatment have 
pain, and more than 75% of patients with advanced disease experience pain. In order to 
help alleviate cancer related pain, the NCCN has provided NPs and other providers with a 
comprehensive set of guidelines to follow in practice. These guidelines are evidence 
based from years of research on the treatment of cancer related pain and have been 
reviewed by the world’s leading clinicians in oncology care. NPs can continue to 
advocate for patients on all levels by encouraging other members of the healthcare 
workforce to utilize the most current evidence based guidelines in practice.  
This project can be used for future research into cancer related pain treatment 
options and their benefit in NP practice. NPs have the compassion and knowledge to 
work in oncology settings; however, the results from this project show that it is equally 
important to educate NPs on how to treat cancer related pain and what guidelines are 
available to follow in their specialty practice. With the increase of NPs entering the 
oncology workforce and the prevalence of cancer related pain, further education and 
practice requirements on treatment modalities are needed. Patients with cancer will 
benefit greatly from the extra knowledge and skills NPs obtain when they utilize 
evidence based guidelines in practice.   
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APPENDIX A. PROPOSED PROJECT TIMELINE WITH APPROXIMATE 
DATES 
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APPENDIX B. PRE-INTERVENTION QUESTIONNAIRE 
The following questionnaire attempts to identify the methods used to treat adult cancer 
related pain. A cancer diagnosis is further defined as any malignant disorder in which 
cells abnormally grow. Adults are considered to be persons 18 years of age and older.  
The following responses will be in a variety of forms, including multiple choices, yes or 
no questions, and open ended.   
Name: ___________________________________________ 
Address: _________________________________________ 
                _________________________________________ 
Phone number: ____________________________________ 
 
Demographics 
1. Which category below includes your age? 
a. 25-35 
b. 36-45 
c. 46-55 
d. 56-65 
e. 66 or older 
2. What is your gender? 
a. Male 
b. Female 
c. I decline to answer this question 
3. What NP certification do you hold? 
a. Family practice (FNP) 
b. Oncology (ONP) 
c. Women’s health (WHNP) 
d. Pediatric (PNP) 
e. Geriatric (GNP) 
f. Other _____________________ 
4. What is your primary area of practice? 
a. Oncology ambulatory care 
b. Primary ambulatory care 
c. Inpatient hospital care 
d. Other _____________________ 
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5. How many years have you been practicing as a NP? 
a. 0-5 years 
b. 6-10 years 
c. 11-15 years 
d. 16-20 years 
e. >20 years 
6. How many hours do you spend in clinical practice per week? 
a. 10 or less 
b. 11-20 hours 
c. 21-30 hours 
d. 31-40 hours 
e. 41 hours or more 
7. What is the average number of oncology patients you see per week? 
a. 1-10 
b. 11-20 
c. 21-30 
d. 31-40 
e. 41-50 
f. >50 
National Comprehensive Cancer Network (NCCN) Guidelines 
8. What guidelines do you currently follow when treating cancer related pain? 
________________________________________________________________ 
9. How familiar are you with the National Comprehensive Cancer Network’s 
(NCCN) 2011 guidelines on the treatment of adult cancer related pain? 
a. Very familiar, I utilize them frequently in practice 
b. Somewhat familiar, I have utilized them a couple times in practice 
c. Somewhat unfamiliar, I have heard of them but have never utilized them 
in practice 
d. Very unfamiliar, I have never heard of them and do not utilize them in 
practice 
10. What, if any, barriers have you encountered in utilizing the 2011 NCCN adult 
cancer pain guidelines? 
a. Lack of education on the guidelines 
b. Use different guidelines for treating cancer related pain 
c. Have not heard of the 2011 NCCN adult cancer pain treatment guidelines 
d. Have not had time to look over the specific recommendations of the 
NCCN 2011 guidelines 
e. Other __________________________________________________ 
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11. In your opinion, do you feel that having the algorithms and guidelines provided 
by the NCCN on the treatment of adult cancer related pain will increase 
utilization and understanding? 
a. Yes 
b. Somewhat 
c. Maybe 
d. Probably not 
e. Definitely not 
12. What challenges have you encountered during the management of cancer related 
pain?  
ONLINE VERSION ONLY: 
13. By clicking ‘Yes’, you agree to utilize the National Comprehensive Cancer 
Network’s guidelines for the treatment of adult cancer related pain in practice. 
This agreement is for the minimum duration of one month and not longer than 3 
months. You can utilize the guidelines in any of the provided forms you desire. 
You understand that no punishment will be inflicted upon you by choosing to 
utilize these guidelines. You may, at any time, stop using the guidelines if you 
find they are not benefiting your practice. 
a. Yes 
b. No 
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APPENDIX C. POST-INTERVENTION QUESTIONNAIRE 
The following questionnaire attempts to identify the methods used to treat adult cancer 
related pain. A cancer diagnosis is further defined as any malignant disorder in which 
cells abnormally grow. Adults are considered to be persons 18 years of age and older.  
The following responses will be in a variety of forms, including multiple choices, yes or 
no questions, and open ended.   
Name: ___________________________________________ 
Address: _________________________________________ 
                _________________________________________ 
Phone number: ____________________________________ 
 
National Comprehensive Cancer Network (NCCN) Guidelines 
Please answer the following four questions based on UTILIZATION of the guidelines: 
1. I utilized the guidelines in practice after they were distributed. 
 
1        2          3         4   5  
Strongly Disagree Disagree Undecided    Agree Strongly 
Agree 
 
2. I continue to utilize the guidelines in practice. 
1        2          3         4   5  
Strongly Disagree Disagree Undecided    Agree Strongly 
Agree 
 
3. The guidelines and algorithms provided increased my knowledge of cancer 
related pain treatment modalities. 
 
1        2          3         4   5  
Strongly Disagree Disagree Undecided    Agree Strongly 
Agree 
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4. The guidelines and algorithms are a useful tool to have in practice. 
 
1        2          3         4   5  
Strongly Disagree Disagree Undecided    Agree Strongly 
Agree 
 
5. What helped to enable your usage of the guidelines in practice? 
a. Having the full set of guidelines available 
b. Having a pocketbook available of the algorithms and treatment options 
c. Having the option to utilize a phone application of the guidelines 
d. Having a desire to learn more about treatment options 
e. Other 
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____ 
6. What, if any, barriers have you encountered in utilizing the 2011 NCCN adult 
cancer pain guidelines? 
a. Lack of education on the guidelines 
b. Use different guidelines for treating cancer related pain 
c. Have not heard of the 2011 NCCN adult cancer pain treatment guidelines 
d. Have not had time to look over the specific recommendations of the 
NCCN 2011 guidelines 
e. Other 
____________________________________________________________
____________________________________________________________ 
 
7. Please provide specific information on how you feel the guidelines helped to 
improve your practice.  
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
8. Please provide any additional comments you have in regards to the NCCN 
guidelines or suggestions which would help improve pain management outcomes 
in cancer care. 
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
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APPENDIX D. NCCN PERMISSION FOR REDISTRIBUTION 
  
 
March 6, 2012 
 
 
Lisa Schoenberg 
NDSU DNP Student 
North Dakota State University 
4518 10th St W 
West Fargo, ND 58078 
 
On behalf of the National Comprehensive Cancer Network®  (NCCN®), I am writing to grant you 
permission to reproduce the NCCN Clinical Practice Guidelines in Oncology (NCCN 
Guidelines®) for Adult Cancer Pain (V.2.2011) as described in your original request to 
distribute the guideline in a professional printed, spiral-bound book for use in practice. 
Permission is 
granted solely for the purposes described herein, which you represent and warrant to be for 
non- promotional educational use only. The following qualifications also apply to the 
permission granted by this letter: 
 
1.   You agree to include a citation giving full credit to the NCCN Guidelines® as follows: 
Reproduced with permission from the NCCN Clinical Practice Guidelines in 
Oncology (NCCN Guidelines®) for Adult Cancer Pain (V.2.2011) © 2012 National 
Comprehensive Cancer Network, Inc. Available at: NCCN.org. Accessed [Month and 
Day, Year]. To view the most recent and complete version of the NCCN Guidelines®, 
go on-line to NCCN.org. 
 
2.   Permission is granted solely for the purposes described within your original request and 
expires after one year. An extension on your permission request may be requested at that 
time. 
 
3.   You agree that you will not translate, change, adapt, delete, extract portions, or modify the 
content of the NCCN Guidelines®  for Adult Cancer Pain (V.2.2011), unless explicit 
permission is provided above. 
 
4.   Permission is for reproduction of the NCCN Guidelines in print media only. No Electronic 
Rights (including CD-ROM and Internet) are granted. Reproduction of the NCCN 
Guidelines into any other medium, including but not limited to electronic media, is explicitly 
prohibited. You further agree that any reproduction of the NCCN Guidelines will include 
NCCN’s URL address  www.nccn.org, to link to the most updated version of the NCCN 
Guidelines for Adult Cancer Pain (V.2.2011). 
 
5.   Permission is granted for reproduction in the English language only. 
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 6.   You acknowledge that the NCCN is sole owner of the NCCN Guidelines, and any 
derivative works created from the guidelines. You further acknowledge that National 
Comprehensive Cancer Network®, NCCN®, NCCN Guidelines®, NCCN Compendium®, 
NCCN Templates®, GUS™, NCCN Flash Updates™, NCCN Trends™ Surveys & Data, 
and NCCN Oncology Insights Reports™ are trademarks owned by the National 
Comprehensive Cancer Network, Inc. You agree that you shall not use the Marks in any 
manner or for any purpose other than to acknowledge ownership of the NCCN Guidelines 
as described in this letter. Your use of the Marks and/or Guidelines for the purposes 
described herein in no way constitutes an endorsement of your works or opinions by the 
NCCN. You acknowledge that use of the Marks and reprinting of the Guidelines pursuant 
to the permission granted hereunder shall not create in your favor any right, title, or interest 
in or to the Marks and/or the Guidelines. The permission granted hereunder is for a one-
time use of the Marks and/or Guidelines. You agree that each use of the Marks and/or the 
Guidelines by you, beyond or in addition to that described herein, shall require written 
approval by the NCCN. 
 
7.   Your use of the Marks and/or Guidelines as described herein shall signify your acceptance 
of the terms and conditions of this letter. The NCCN reserves the right to at any time revoke 
the permission granted hereunder if, in its discretion, the NCCN determines that you have 
violated or are in violation of the terms of this letter of permission. 
 
 
Thank you for your interest in the work of the NCCN. 
 
 
Sincerely, 
 
 
Nicole B. Fair 
Manager, Continuing Education and Grants 
National Comprehensive Cancer Network 
 
 
 
Additional Information on the NCCN Guidelines: 
The NCCN Guidelines®   - the recognized standard for clinical policy in oncology - are the most 
comprehensive and most frequently updated clinical practice guidelines available in any area of medicine. 
Covering 97 percent of all patients with cancer and updated on a continual basis, the NCCN Guidelines are 
developed through an explicit review of the evidence integrated with expert medical judgment and 
recommendations by multidisciplinary panels from NCCN Member Institutions. There are 44 individual 
panels, comprising nearly 900 clinicians and oncology researchers from the 21 NCCN Member Institutions 
and their affiliates. Specific treatment recommendations are implemented through performance 
measurement. NCCN Guidelines Panels address cancer detection, prevention and risk reduction, workup 
and diagnosis, treatment, and supportive care. 
 
NCCN Guidelines have become the most widely used guidelines in oncology practice and have been 
requested by 
cancer care professionals in more than 115 countries. There has also been substantial 
international interest in translating the NCCN Guidelines into a variety of languages. Select 
NCCN Guidelines have been translated into Chinese, German, Italian, Japanese, Korean, Polish, 
Portuguese, Russian, Spanish, and Turkish. 
64 
 
APPENDIX E. AGREEMENT FOR USE OF THE NCCN GUIDELINES 
 
I, ____________________________________, agree to utilize the National 
Comprehensive Cancer Network’s guidelines in the treatment of adult cancer related pain 
in practice. This agreement is for the minimum duration of one month and not longer than 
3 months. I can utilize the guidelines in any of the provided forms I desire. I understand 
that no punishment will be inflicted upon me by choosing to utilize these guidelines. I 
may, at any time, stop using the guidelines if I find they are not benefiting my practice.  
 
Name 
___________________________________________________________________ 
 
Signature 
_________________________________________________________________ 
 
Date _________________________ 
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APPENDIX F. INSTRUCTIONS FOR PHONE APPLICATION OF THE NCCN 
GUIDELINES 
 
Access the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) 
anywhere and at anytime through free NCCN Guidelines mobile apps for iPhone and 
Android. 
Recent data continues to indicate that clinicians are increasingly using smartphones to 
access medical information and bring faster, more informed decision-making to the point 
of care. 
These new NCCN apps enable clinicians to easily access the NCCN Guidelines, which 
are updated on a continual basis and developed through an explicit review of the evidence 
integrated with expert medical judgment and recommendations by multidisciplinary 
panels from NCCN Member Institutions. 
The NCCN Guidelines apps for iPhone and Android are free to download through 
the iTunes Store and Android Market. To use the NCCN Guidelines apps, an 
individual must be a registered user on NCCN.org. There is no fee to become a registered 
user on NCCN.org and to view the NCCN Guidelines. 
iPhone Installation Instructions 
To download the NCCN Guidelines™ app to your iPhone or iPod touch, follow these 
simple steps:  
• Open the App store, select Search at the bottom and enter NCCN in the search box. 
• Tap the Get App button.  
• Tap the Install button.  
• Enter iTunes user ID and password (these are different from your NCCN username 
and password).  
• Return to your iPhone home screen and tap on the NCCN Guidelines™ icon.  
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• When application is installed, tap on the NCCN icon and follow the on-screen 
instructions. 
• Once the NCCN Guidelines™ app launches, you will see a License Agreement. You 
will need to read and accept the license agreement to continue. 
• You must be a registered user on the NCCN.org web site to access the guidelines. 
On the log in page, you can either enter you log in information or you can select the 
register button to register as a new user on NCCN.org. 
Android Installation Instructions 
This application is compatible with Android devices with version 1.5 or higher.  
To download the NCCN Guidelines™ app to your Android, follow these simple steps:  
1. You can use the bar code scanner on the phone to scan the bar code at the bottom 
of this page. This will automatically load the page from the Android Market with 
the NCCN Guidelines™ app. 
2. Alternatively, tap the “Market” icon and search for “NCCN” 
3. Select NCCN Guidelines™ and tap on “Install”. When the warning appears, tap 
the “Ok” button. 
4. When application is installed, tap on the NCCN icon and follow the on-screen 
instructions. 
5. Once the NCCN Guidelines™ app launches, you will see a License Agreement. 
You will need to read and accept the license agreement to continue. 
6. You must be a registered user on the NCCN.org web site to access the guidelines. 
On the log in page, you can either enter you log in information or you can select 
the register button to register as a new user on NCCN.org. 
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